Around 350 million people worldwide are living with a rare disease. These are often genetically determined and cannot be immediately or easily diagnosed. The RDI’s goal is to raise awareness and build trust around digital health solutions that can help people with rare diseases.
“Ada” is a symptom assessment tool that was developed by a team of scientists and doctors.
It asks you detailed questions about your symptoms and, based on your answers, will deduce the possible causes of those symptoms.
For rare diseases, Ada’s symptom assessment can provide patients and doctors with an early warning sign that a rare disease could be the underlying cause for the symptoms.
This web-based application is provided by Ada Health GmbH (“Ada”). Processing of personal data is performed exclusively by Ada in accordance with GDPR guidelines. (See Ada’s data privacy policy here)
This website is part of the Rare Disease Initiative (“RDI”). Ada Health GmbH (“Ada”) and Novartis Pharma GmbH (“Novartis”) have initiated the RDI in 2019 to advocate for better treatment of rare diseases. The RDI is open to new members. Ada holds full responsibility for the initiative while Novartis provided financial support.